Takeda Plots New Rozerem Campaign?
MM&M reports that "The whimsical consumer campaign for Takeda's insomnia drug Rozerem has generated lots of buzz, just not the kind of recognition that...
Brandweek Hires Peter Rost, Moves to the Dark Side!
The pharmaceutical industry often complains that the "media" are unfriendly and biased against the industry. And at least one blog that shills for the...
The Drug Advertising Blame Game
In case you are wondering who and what to blame for everything evil about the pharmaceutical industry, consider the list of "10 reforms that...
A Tale of Two Pharma Whistleblower Novels
Big Pharma and Killer Drug
A Tale of Two Pharma Whistleblower Novels
Big Pharma and Killer Drug
A Tale of Two Pharma Whistleblower Novels
Big Pharma and Killer Drug
The Changing Landscape of Physician Interactions
Strategies to Improve Interactions with Key Physicians
Stop Wasting Millions on Ineffective DTC Ads!
Testing Technology Can Help Improve Ads and Engage Viewers
Merck Rejiggers Its Marketing Mix: Will Other Pharma Companies Follow?
Adam Schechter, President of Merck US Human Health, made this statement not long ago at a Goldman Sachs healthcare conference: 'Industry must embrace new ways of engaging physicians on their terms.'
J&J’s PR Hindenburg Disaster!
Johnson and Johnson's recent announcement that it is filing a civil suit against the American Red Cross (ARC) has been called one of the worst PR moves ever made by a pharmaceutical company and one that has completely flushed away the goodwill the company earned years ago by its adroit handling of the Tylenol tampering crisis.
